Trials / Recruiting
RecruitingNCT02834884
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,975 (estimated)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.
Detailed description
Patients are recruited in the platform for the research purpose of 5 downstream projects. For more information, please have a look at the "Groups and cohorts" section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | RP-1828 IMMUcan | WES, lcWGS and RNAseq, multiplex IF and IMC |
| GENETIC | RP-1759 AYA/TYA | WES, RNAseq and EPIC array |
| GENETIC | RP-1843 Arcagen | NGS panel |
| GENETIC | RP-1920 BioRadon | NGS panel |
| GENETIC | 2148 MRD | ctDNA detection and WES |
Timeline
- Start date
- 2017-05-03
- Primary completion
- 2022-08-29
- Completion
- 2031-10-01
- First posted
- 2016-07-15
- Last updated
- 2026-04-17
Locations
134 sites across 20 countries: Austria, Belgium, Croatia, Cyprus, Czechia, Estonia, France, Germany, Greece, Italy, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Slovenia, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02834884. Inclusion in this directory is not an endorsement.